Both PROTAC 34 and parent inhibitor 6 induced a similar transcriptional response in AML cells, suggesting that the transcriptional role of CDK6 in AML is mainly limited to its kinase-dependent function. This evidence concerns the gene CDK6 and acute myeloid leukemia.